Clinical Trials on Late Platelet Aggregation in Switzerland
Total 52 results
-
Kantonsspital GraubündenCompletedPlatelet Aggregation | Endothelial FunctionSwitzerland
-
Insel Gruppe AG, University Hospital BernRecruitingCoronary Artery Disease | Percutaneous Coronary Intervention | Platelet Aggregation InhibitorsSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedMyocardial Ischemia | Thrombosis | Coronary Artery Bypass Graft Triple Vessel | Antithrombotic Drugs [Platelet-aggregation Inhibitors] Causing Adverse Effects in Therapeutic UseSwitzerland
-
University Hospital Inselspital, BerneEuropean Cardiovascular Research CenterCompletedCoronary Artery Disease | Platelet-aggregation InhibitorsBulgaria, Switzerland, Austria, Belgium, Germany, Italy, Netherlands, Poland, United Kingdom
-
Kantonsspital AarauRecruiting
-
University of ZurichUniversity Children's Hospital BaselCompletedLate-effects of Childhood CancerSwitzerland
-
University of BernRecruitingChildhood Cancer | Late EffectSwitzerland
-
University Hospital, GenevaCompletedAcquired Platelet DisorderSwitzerland
-
Insel Gruppe AG, University Hospital BernUniversity of Zurich; University Hospital, GenevaNot yet recruiting
-
University of Lausanne HospitalsCompleted
-
University Hospital, Basel, SwitzerlandRecruitingInsulin Resistance | Body Composition | Glucose Tolerance | Gastrointestinal Tolerance | Thrombocyte Aggregation | Blood p-Selectin | Blood ErythritolSwitzerland
-
University Hospital, Basel, SwitzerlandEnrolling by invitationAnalysis Transmission RateSwitzerland
-
University of ZurichUniversity of California, Los Angeles; University of Bologna; University of Southern... and other collaboratorsCompletedLiver Transplantation | Aortohepatic Conduit | Patency RateSwitzerland
-
University Hospital, GenevaRecruitingChildhood Cancer | Genetic Predisposition | Late EffectSwitzerland
-
Schulthess KlinikCompletedDevice Success Rate | Device PerformanceSwitzerland, Austria
-
La Tour HospitalRive Droite SAUnknownPlatelet-rich Plasma (PRP) | Supraspinatis Interstitial Partial-thickness TearsSwitzerland
-
Aktiia SARecruitingHypertension | Blood Pressure | Heart RateSwitzerland
-
Swiss Paraplegic Centre NottwilCompletedWheelchairs | Dietary Supplements | Heart Rate/Drug Effects | Lactic Acid/Metabolism | Physical Education and Training/MethodsSwitzerland
-
University Hospital Inselspital, BerneCompletedEvaluation of Success Rate | Airway Leak Pressure | Side Effects of LMA Supreme in Pediatric Patients Undergoing General AnesthesiaSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedBariatric Surgery | Postprandial Hypoglycemia | Late Dumping SyndromeSwitzerland
-
Emma Marie Caroline SlackUniversity of Zurich; University Children's Hospital, ZurichCompletedLate-Onset Neonatal Sepsis | Necrotising EnterocolitisSwitzerland
-
Fliegerärztliches InstitutUniversity of LausanneCompletedHeart Rate Variability | Cerebral Oxygenation | Oxygen Saturation | Baro-reflex Sensitivity | EEG, Microstates | Cerebral Blood Flow Regulation | Concentration PerformanceSwitzerland
-
Georg Kägi, MDUniversity Hospital, Basel, Switzerland; Cantonal Hospital of Aarau, SwitzerlandRecruiting
-
Alain KaelinClinical Trial Unit Ente Ospedaliero CantonaleRecruitingIdiopathic Parkinson's Disease (at Later Stage)Switzerland
-
University Children's Hospital, ZurichCompletedHemolytic-Uremic Syndrome | Children | Parents | Psychological AdjustmentSwitzerland
-
Dr Yan BeauverdCompletedPolycythemia Vera | Thrombocythemia, EssentialSwitzerland, United Kingdom
-
University Hospital, Basel, SwitzerlandCompletedBleeding | Aortic Stenosis | Von Willebrand DiseaseSwitzerland
-
University Children's Hospital BaselNovartis Pharmaceuticals; Stiftung zur Förderung medizinischer und biologischer... and other collaboratorsActive, not recruiting
-
European Organisation for Research and Treatment...AmgenWithdrawnFirst Progression of MGMT Promoter-methylated GlioblastomaSpain, Switzerland
-
University Hospital, Basel, SwitzerlandUniversity Children's Hospital BaselCompletedImmune ThrombocytopeniaSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myeloproliferative NeoplasmSwitzerland
-
Geron CorporationCompletedPolycythemia Vera | Essential ThrombocythemiaUnited States, Germany, Switzerland
-
European Research Consortium on ITPFondazione Progetto EmatologiaCompletedPrimary Immune Thrombocytopenia (ITP)Spain, Switzerland, United Kingdom, Italy, France, Norway
-
ShireCompletedEssential Thrombocythemia (ET)United Kingdom, Italy, Czechia, France, Germany, Greece, Spain, Switzerland
-
Baxalta now part of ShireCompletedHereditary Thrombotic Thrombocytopenic Purpura (TTP)United States, Germany, United Kingdom, Switzerland, Austria, Japan, Poland
-
Insel Gruppe AG, University Hospital BernSwiss National Science Foundation; Mach Gaensslen Foundation; Baxalta Innovations...RecruitingThrombotic Thrombocytopenic Purpura | Congenital Thrombotic Thrombocytopenic Purpura | Familial Thrombotic Thrombocytopenic Purpura | Thrombotic Thrombocytopenic Purpura, Congenital | Upshaw-Schulman SyndromeUnited States, Austria, Czechia, Germany, Japan, Norway, Switzerland
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Glanzmann's DiseaseSpain, Bulgaria, Pakistan, Belgium, Germany, France, United Kingdom, Italy, Hungary, Netherlands, United States, Algeria, Austria, Sweden, Switzerland
-
Swedish Orphan BiovitrumActive, not recruitingImmune Thrombocytopenia | ITPCroatia, Czechia, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom
-
SanofiCompletedAcquired Thrombotic Thrombocytopenic PurpuraUnited States, Austria, Belgium, Canada, Czechia, France, Hungary, Israel, Italy, Spain, Switzerland, Turkey, United Kingdom
-
Ablynx, a Sanofi companyCompletedAcquired Thrombotic Thrombocytopenic PurpuraUnited States, Austria, Belgium, France, Germany, Israel, Italy, Spain, Switzerland, United Kingdom, Bulgaria, Romania, Australia
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.RecruitingThrombotic Thrombocytopenic Purpura (TTP)United States, Spain, Poland, Italy, Germany, France, Switzerland, Austria, Japan, United Kingdom
-
Novartis PharmaceuticalsCompletedImmune Thrombocytopenic Purpura (ITP)Spain, Italy, Greece, Switzerland, United Kingdom, France, Turkey, Russian Federation, Brazil, Austria, Mexico, Oman, Chile, Japan, United States
-
TakedaShire; Takeda Development Center Americas, Inc.RecruitingThrombotic Thrombocytopenic Purpura (TTP)China, United States, France, Japan, Poland, Germany, Austria, Spain, Italy, Switzerland, United Kingdom
-
Novartis PharmaceuticalsTerminatedThrombocytopaeniaUnited States, Belgium, Australia, Canada, Hong Kong, Austria, Brazil, Czechia, Israel, Russian Federation, Spain, Sweden, Thailand, Denmark, France, Germany, Ireland, Italy, Korea, Republic of, Peru, Switzerland, Taiwan, Turkey, Hungary and more
-
AmgenCompletedImmune ThrombocytopeniaUnited States, Canada, Belgium, Czechia, Mexico, Turkey, Australia, Spain, France, Israel, Hungary, South Africa, Poland, Russian Federation, United Kingdom, Brazil, Switzerland
-
AlexionCompletedAtypical Hemolytic Uremic Syndrome (aHUS)United States, France, Germany, Spain, Switzerland, Netherlands, Canada, Austria
-
Alexion PharmaceuticalsTerminatedAtypical Hemolytic Uremic SyndromeFrance, Canada, United States, Belgium, Italy, United Kingdom, Netherlands, Australia, Austria, Germany, Sweden, Switzerland
-
Ablynx, a Sanofi companyCompletedAcquired Thrombotic Thrombocytopenic PurpuraUnited States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Hungary, Israel, Italy, Netherlands, Spain, Switzerland, Turkey, United Kingdom